Search

Author/Creator Binder, P.

2. Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy. (22nd December 2016)

Authors:
Moore, M.; Gill, S.; Asmis, T.; Berry, S.; Burkes, R.; Zbuk, K.; Alcindor, T.; Jeyakumar, A.; Chan, T.; Rao, S.; Spratlin, J.; Tang, P. A.; Rothenstein, J.; Chan, E.; Bendell, J.; Kudrik, F.; Kauh, J.; Tang, S.; Gao, L.; Kambhampati, S. R. P.
Journal:
Annals of oncology
Issue:
Volume 27:Number 12(2016:Dec.)
Page Start:
2216
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search